Interleukin-15, IL-15 Receptor-Alpha, and Obesity: Concordance of Laboratory Animal and Human Genetic Studies
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Interleukin-15 (IL-15) is a cytokine which inhibits lipid deposition in cultured adipocytes and decreases adipose tissue deposition in laboratory rodents. In human subjects, negative correlations between circulating IL-15 levels and both total and abdominal fat have been demonstrated. Deletions of IL15 in humans and mice are associated with obesity, while gain-of-function IL-15 overexpressing mice are resistant to diet-induced obesity. IL-15 is highly (but not exclusively) expressed at the mRNA level in skeletal muscle tissue, and the regulation of IL-15 translation and secretion is complex. Conflicting evidence exists concerning whether circulating IL-15 is released from skeletal muscle tissue in response to exercise or other physiological stimuli. The IL-15 receptor-alpha (IL-15R α) subunit has a complex biochemistry, encoding both membrane-bound and soluble forms which can modulate IL-15 secretion and bioactivity. The gene encoding this receptor,IL15RA,resides on human chromosome 10p, a location linked to obesity and type-2 diabetes. Several single-nucleotide polymorphisms (SNPs) in human IL15RA and IL15 correlate with adiposity and markers of the metabolic syndrome. Genetic variation in IL15RA may modulate IL-15 bioavailability, which in turn regulates adiposity. Thus, IL-15 and the IL-15R α may be novel targets for pharmacologic control of obesity in the human population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Altered energy balance resulting in obesity is believed to be causal in the development of the metabolic syndrome and type-2 diabetes mellitus, conditions whose incidence is also rising at alarming rates [2, 3].”
BackgroundHarris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Obesity and the Environment: Where Do We Go from Here?
Hill, J. O., Wyatt, H. R., Reed, G. W., & Peters, J. C. (2003) · Science · doi:10.1126/science.1079857 · Cited by 2,180 · cited 2×
“is currently in excess of $200 billion annually, and it is expected to rise [1].”
BackgroundInterleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk
Pedersen, B. K. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179515 · Cited by 631 · cited 1×
“Since both IL-15 and physical exercise have positive effects on body composition, it is reasonable to hypothesize IL-15 release following exercise may mediate some of the beneficial effects of physical activity [16, 54].”
BackgroundNieman, D. C., Davis, J. M., Henson, D. A., Walberg-Rankin, J., Shute, M., Dumke, C. L., Utter, A. C., Vinci, D. M., Carson, J. A., Brown, A., et al. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01130.2002 · Cited by 353
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity
Quinn, L. S., Anderson, B. G., Strait-Bodey, L., Stroud, A. M., & Argilés, J. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90506.2008 · Cited by 267 · cited 4×
“Conversely, transgenic mice which were engineered for elevated circulating levels of IL-15 (IL-15 Tg mice), expressed from a skeletal muscle-specific promoter, exhibited lower levels of body fat than closely related controls, and were resistant to diet-induced obesity [42].”
BackgroundInfluentialNielsen, A. R., Mounier, R., Plomgaard, P., Mortensen, O. H., Penkowa, M., Speerschneider, T., Pilegaard, H., & Pedersen, B. K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.139618 · Cited by 266
Christiansen, T., Paulsen, S. K., Bruun, J. M., Pedersen, S. B., & Richelsen, B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00574.2009 · Cited by 255
Quinn, L. S., Anderson, B. G., Drivdahl, R. H., Alvarez, B., & Argilés, J. M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5624 · Cited by 226 · cited 3×
“In contrast to adipose tissue, IL-15 mRNA and protein expression has been observed consistently in skeletal muscle and skeletal muscle-derived culture systems [23, 48– 51], where it functions to modulate myofibrillar protein dynamics [23, 44].”
BackgroundHansen, J., Brandt, C., Nielsen, A. R., Hojman, P., Whitham, M., Febbraio, M. A., Pedersen, B. K., & Plomgaard, P. (2011) · Endocrinology · doi:10.1210/en.2010-0868 · Cited by 200 · cited 1×
“For example, although skeletal muscle expresses the myostatin-inhibiting factor follistatin, a recent study provided evidence that the postexercise rise in circulating follistatin is mostly likely derived from the liver rather than from muscle tissue [59].”
BackgroundQUINN, L., STRAITBODEY, L., ANDERSON, B., ARGILES, J., & HAVEL, P. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.02.005 · Cited by 199 · cited 6×
“In this regard, human genetic studies by three separate laboratories have identified several single-nucleotide polymorphisms (SNPs) in IL15RA which impact muscularity, fat deposition, and markers of the metabolic syndrome [13, 14, 19].”
BackgroundCarbó, N., López-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F. M., Quinn, L. S., López-Soriano, F. J., & Argilés, J. M. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00188-4 · Cited by 174 · cited 4×
“In contrast, using sedentary postmenopausal women, Prestes et al. [57] reported an increase in plasma IL-15 levels 48 hours following the first session of resistance training but no effect following 16 weeks of training.”
BackgroundMethodInfluentialCalcium and 1,25‐Dihydroxyvitamin D3 Regulation of Adipokine Expression
Sun, X., & Zemel, M. B. (2007) · Obesity · doi:10.1038/oby.2007.540 · Cited by 137 · cited 2×
“Further work is needed to confirm and expand this observation.”
BackgroundInterleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes
Barra, N. G., Reid, S., MacKenzie, R., Werstuck, G., Trigatti, B. L., Richards, C., Holloway, A. C., & Ashkar, A. A. (2010) · Obesity · doi:10.1038/oby.2009.445 · Cited by 116 · cited 8×
“Importantly, inhibition of fat deposition was observed in the absence of an effect of IL-15 on food consumption [13, 40].”
BackgroundInfluentialMarzetti, E., Carter, C. S., Wohlgemuth, S. E., Lees, H. A., Giovannini, S., Anderson, B., Quinn, L. S., & Leeuwenburgh, C. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.008 · Cited by 113 · cited 1×
“In another study [65], a similar decline in muscle IL-15 protein levels (and muscle IL-15Rα mRNA expression) in ad lib-fed rats was described, but no declines in IL-15 protein levels or IL-15Rα mRNA expression were observed in long-lived, calorie-restricted rats [65].”
BackgroundSelf-citationLong-Term Physical Activity and Inflammatory Biomarkers in Older Adults
BEAVERS, K. M., HSU, F.-C., ISOM, S., KRITCHEVSKY, S. B., CHURCH, T., GOODPASTER, B., PAHOR, M., & NICKLAS, B. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e3ac80 · Cited by 108
Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits
Kubota, T., Brown, R. A., Fang, J., & Krueger, J. M. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.3.r1004 · Cited by 51 · cited 3×
“However, IL-15 expression, trafficking and effects in the CNS are an additional, relatively unexplored area of investigation which could impact the balance of energy expenditure and energy intake.”
Background
Cited by
Exercise is the real polypill.
Fiuza-Luces, C., Garatachea, N., Berger, N. A., & Lucia, A. (2013) · Physiology · doi:10.1152/physiol.00019.2013 · Cited by 791
“In addition to its local anabolic/anti-catabolic effects (59, 60, 135, 338, 390, 391), IL-15 plays an anti-obesogenic effect (337, 388), mainly by inhibiting lipid deposition (8 –10, 24, 59, 136, 389).”
BackgroundSkeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Pedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516
“Conclusion LIF is a newly discovered myokine, which is induced in skeletal muscle following”
Exercise Attenuates the Major Hallmarks of Aging
Garatachea, N., Pareja-Galeano, H., Sanchis-Gomar, F., Santos-Lozano, A., Fiuza-Luces, C., Morán, M., Emanuele, E., Joyner, M. J., & Lucia, A. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1623 · Cited by 413
Kwon, J. H., Moon, K. M., & Min, K.-W. (2020) · Healthcare · doi:10.3390/healthcare8040378 · Cited by 116
Metadata
- Authors
- Quinn, L. S., & Anderson, B. G.
- Venue
- Journal of Obesity
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-8
- ISSN
- 2090-0708 (ISSN-L)
- 2090-0716
- OpenAlex
- W2037500958
- Cited by
- 72
- References
- 18
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.